Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lipid nanoparticles containing 5-fluorouracil and triamcinolone acetonide for hypertrophic scars
IRCT20250417065368N1Phase 2Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- May 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of fluorouracil and triamcinolone acetonide in Hypertrophic Scar (HS), sponsored by Tabriz University of Medical Sciences. Started May 2025; status: completed.
02
Drugs
fluorouraciltriamcinolone acetonide
03
Conditions
Hypertrophic Scar (HS)
Beyond the preview
Go deeper on IRCT20250417065368N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250417065368N1.